- Home
- SHIP vs NTHI Comparison
SHIP vs NTHI Comparison
Compare SHIP & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHIP | NTHI |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 287.6M | 243.9M |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | SHIP | NTHI |
|---|---|---|
| Price | $13.15 | $7.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 289.8K | 26.8K |
| Earning Date | 02-17-2026 | 02-23-2026 |
| Dividend Yield | ★ 3.55% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.33 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.34 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.79 | $3.20 |
| 52 Week High | $14.93 | $16.00 |
Technical Indicators
Market Signals| Indicator | SHIP | NTHI |
|---|---|---|
| Relative Strength Index (RSI) | 54.41 | 37.51 |
| Support Level | $7.85 | $5.25 |
| Resistance Level | $14.93 | $10.52 |
| Average True Range (ATR) | 0.61 | 0.70 |
| MACD | -0.19 | -0.19 |
| Stochastic Oscillator | 44.59 | 19.31 |
Price Performance
Historical ComparisonAbout SHIP Seanergy Maritime Holdings Corp.
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.
About NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).